BEONE MEDICINES LTD.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $202.1M | $6.13B | $4.38B |
| FY2022 | $209.1M | $4.38B | $3.87B |
| FY2023 | $197.6M | $3.54B | $3.17B |
| FY2024 | $166.5M | $3.33B | $2.63B |
| FY2025 | $961.9M | $4.36B | $4.55B |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2021 | $202.1M | $6.13B | $4.38B |
| FY2022 | $209.1M | $4.38B | $3.87B |
| FY2023 | $197.6M | $3.54B | $3.17B |
| FY2024 | $166.5M | $3.33B | $2.63B |
| FY2025 | $961.9M | $4.36B | $4.55B |